Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity
Autore:
Ginsberg, GM; Slater, PE; Shouval, D;
Indirizzi:
Minist Hlth, Med Technol Assessment Sector, IL-93509 Jerusalem, Israel Minist Hlth Jerusalem Israel IL-93509 Sector, IL-93509 Jerusalem, Israel Minist Hlth, Dept Epidemiol, IL-93509 Jerusalem, Israel Minist Hlth Jerusalem Israel IL-93509 demiol, IL-93509 Jerusalem, Israel Hadassah Hosp, Liver Unit, Jerusalem, Israel Hadassah Hosp Jerusalem Israel ssah Hosp, Liver Unit, Jerusalem, Israel
Titolo Testata:
JOURNAL OF HEPATOLOGY
fascicolo: 1, volume: 34, anno: 2001,
pagine: 92 - 99
SICI:
0168-8278(200101)34:1<92:CAOANI>2.0.ZU;2-M
Fonte:
ISI
Lingua:
ENG
Soggetto:
A VACCINE; VIRAL-HEPATITIS; ECONOMIC-ANALYSIS; VIRUS; PROPHYLAXIS; PREVENTION; INFECTION; OUTBREAK; ANTIBODIES; PROTECTION;
Keywords:
cost-benefit analysis; hepatitis A; liver transplants; vaccinations;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
75
Recensione:
Indirizzi per estratti:
Indirizzo: Ginsberg, GM Minist Hlth, Med Technol Assessment Sector, Dan 8, IL-93509 Jerusalem, Israel Minist Hlth Dan 8 Jerusalem Israel IL-93509 erusalem, Israel
Citazione:
G.M. Ginsberg et al., "Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity", J HEPATOL, 34(1), 2001, pp. 92-99

Abstract

Background/Aims: The availability of safe and effective Hepatitis A vaccines prompts an evaluation of a nationwide infant vaccination campaign to supplement strategies aimed at high-risk groups such as travellers and military personnel. Methods: A spreadsheet model was used to estimate costs and benefits of a nationwide infant immunization programme against Hepatitis A for the periodfrom 1997-2014 in Israel. Results: Immunizing all one year olds in Israel from 1997-2014 would for acost of $32.0 million to the health services and $42.1 million to society (including $10.1 million lost work and transport costs), reduce the number of cases of Hepatitis A during the next 35 years from 181 000 to 47 000, This would save $57.5 million in health service resources alone, $32.0 million in averted work absences and transport costs in addition to a further $17.0 million in averted premature mortality costs. The health service, resource and societal benefit:cost ratios are 1.80:1, 2.13:1 and 2.54:1, respectively. Conclusions: The recent adoption of a nationwide infant HAV immunisation policy in Israel is both medically and economically justifiable. (C) 2001 Elsevier Science B.V. Published by Elsevier Science B.V. All rights reserved.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/20 alle ore 23:06:56